Mandibuloacral Dysplasia With Type A Lipodystrophy; Mada
Description
Mandibuloacral dysplasia with type A lipodystrophy (MADA) is an autosomal recessive disorder characterized by growth retardation, craniofacial anomalies with mandibular hypoplasia, skeletal abnormalities with progressive osteolysis of the distal phalanges and clavicles, and pigmentary skin changes. The lipodystrophy is characterized by a marked acral loss of fatty tissue with normal or increased fatty tissue in the neck and trunk. Some patients may show progeroid features. Metabolic complications can arise due to insulin resistance and diabetes (Young et al., 1971; Simha and Garg, 2002; summary by Garavelli et al., 2009).See also MAD type B (MADB ), which is caused by mutation in the ZMPSTE24 gene (OMIM ).
Genes related to Mandibuloacral Dysplasia With Type A Lipodystrophy; Mada
- LMNA
- ZMPSTE24
Clinical Features
Top most frequent phenotypes and symptoms related to Mandibuloacral Dysplasia With Type A Lipodystrophy; Mada
- Short stature
- Generalized hypotonia
- Hearing impairment
- Growth delay
- Neoplasm
- Micrognathia
- Muscle weakness
- Pain
- Cataract
- Flexion contracture
And another 100 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Mandibuloacral Dysplasia With Type A Lipodystrophy; Mada Is also known as craniomandibular dermatodysostosis, lipodystrophy, type a, associated with mandibuloacral dysplasia.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Mandibuloacral Dysplasia With Type A Lipodystrophy; Mada Recommended genes panels
| Panel Name, Specifity and genes Tested/covered |
|---|
 CMT Advanced Evaluation - Dominant, Axonal.
By Athena Diagnostics Inc (United States).
YARS, MFN2, TRPV4, DNM2, HSPB8, GARS, HSPB1, LMNA, MPZ, NEFL, RAB7A
Specificity
10 %
Genes
50 % |
|
CMT Advanced Evaluation - Comprehensive.
By Athena Diagnostics Inc (United States).
YARS, PRX, GDAP1, LITAF, FIG4, MFN2, TRPV4, FGD4, SBF2, SH3TC2, DNM2, HSPB8, EGR2, GARS, GJB1, HSPB1, LMNA, MPZ, MTMR2, NDRG1 , (...)
View the complete list with 3 more genes
Specificity
5 %
Genes
50 % |
|
CMT Advanced Evaluation - Axonal.
By Athena Diagnostics Inc (United States).
YARS, GDAP1, MFN2, TRPV4, DNM2, HSPB8, GARS, GJB1, HSPB1, LMNA, MPZ, NEFL, RAB7A
Specificity
8 %
Genes
50 % |
|
CMT Advanced Evaluation - Recessive.
By Athena Diagnostics Inc (United States).
PRX, GDAP1, FIG4, FGD4, SBF2, SH3TC2, LMNA, MTMR2, NDRG1
Specificity
12 %
Genes
50 % |
|
LMNA (CMT2B1) DNA Sequencing Test.
By Athena Diagnostics Inc (United States).
LMNA
Specificity
100 %
Genes
50 % |
|
Lamin A/C (LMNA) DNA Sequencing Test.
By Athena Diagnostics Inc (United States).
LMNA
Specificity
100 %
Genes
50 % |
|
CMT Advanced Evaluation - Nonprevalent.
By Athena Diagnostics Inc (United States).
YARS, PRX, GDAP1, LITAF, FIG4, TRPV4, FGD4, SBF2, SH3TC2, DNM2, HSPB8, EGR2, GARS, GJB1, HSPB1, LMNA, MTMR2, NDRG1, NEFL, PMP22 , (...)
View the complete list with 1 more genes
Specificity
5 %
Genes
50 % |
|
Emery-Dreifuss Muscular Dystrophy Advanced Sequencing Evaluation.
By Athena Diagnostics Inc (United States).
SYNE2, SYNE1, TMEM43, EMD, FHL1, LMNA
Specificity
17 %
Genes
50 % |
You can get up to 459 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 1; IHPS1 LUTHERAN NULL